Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. EMEA Innovative Medicine /
    2. How we work /
    3. Policy /
    4. Europe treats new medicines as a cost.

    Europe treats new medicines as a cost. By Bruno Costa Gabriel. Transparency Notice

    1. The sponsor: Johnson & Johnson and its Affiliates
    2. The entity ultimately controlling the sponsor: Johnson & Johnson and its Affiliates
    3. The entity paying for the political advertisement: Johnson & Johnson and its Affiliates
    4. The period during which the political advertisement is intended to be published, delivered or disseminated: July 2026
    5. The aggregated amounts and the aggregated value of other benefits received by the providers of political advertising services for the political advertisement: 32,000 GBP
    6. The aggregated amounts and the aggregated value of other benefits received by the providers of political advertising services for the political advertising campaign: 42,000GBP
    7. Information on the origin of the amounts and other benefits received by the providers of political advertising services: private within the EU
    8. The methodology used for the calculation of the aggregated amounts and the aggregated value of other benefits received by the providers of political advertising services for the political advertisement, and where applicable, the political advertising campaign: N/A (no other benefits received)
    9. The political advertisement is linked to: European policy on access to innovative medicines.
    10. Webpage link on official information about the modalities for participation in the election or referendum linked to the political advertisement: https://health.ec.europa.eu/publications/proposal-regulation-establish-measures-strengthen-unions-biotechnology-and-biomanufacturing-sectors_en
    11. Links to the European repository for online political advertisements: To be updated whenever the repository is launched
    12. How to notify possibly non-compliant political advertisements: contact us, FT contact us
    13. A previous publication of the political advertisement or of an earlier version of it has been suspended or discontinued due to an infringement of Regulation (EU): This is N/A as we have not had any not approved.
      USE OF TARGETING and/or AD-DELIVERY TECHNIQUES based on the processing of personal data
    14. The political advertisement has not been subject to targeting techniques and/or ad-delivery techniques based on the use of personal data.
    15. Information about the targeting and/or ad-delivery techniques used: Not applicable.
    16. Effective means supporting individuals to exercise their data protection rights under Regulation (EU) 2016/679 of the European Parliament and of the Council (General Data Protection Regulation), including the right to amend their personal data and withdraw consent to process their personal data for political advertising purposes:
      No personal data is processed by Johnson & Johnson for this advertisement
    July 2026
    CP-593929